June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Integrating gene regulation and single cell expression with genetic associations identifies genes and cell types contributing to primary open angle glaucoma risk and intraocular pressure
Author Affiliations & Notes
  • Ayellet Vered Segre
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Andrew R Hamel
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Jiali Wang
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • John Rouhana
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Tavé van Zyl
    Department of Ophthalmology and Visual Sciences, Yale School of Medicine, New Haven, Connecticut, United States
  • Wenjun Yan
    Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, Massachusetts, United States
  • Alexi mcadams
    Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, Massachusetts, United States
  • Aboozar Monavarfeshani
    Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, Massachusetts, United States
  • Qingnan Liang
    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States
  • Rui Chen
    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States
  • Joshua R. Sanes
    Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, Massachusetts, United States
  • Janey L Wiggs
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Ayellet Segre CytoReason, Code C (Consultant/Contractor); Andrew Hamel None; Jiali Wang Novartis, Code E (Employment); John Rouhana Gritstone Oncology, Code E (Employment); Tavé van Zyl Regeneron Pharmaceuticals, Code E (Employment); Wenjun Yan None; Alexi mcadams None; Aboozar Monavarfeshani None; Qingnan Liang None; Rui Chen None; Joshua Sanes Biogen, Code C (Consultant/Contractor); Janey Wiggs None
  • Footnotes
    Support  NIH/NEI R01 EY031424-01, NIH/NEI P30 EY014104, Chan Zuckerberg Initiative (CZI) Seed Network for the Human Cell Atlas award CZF2019-002459.
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1132. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ayellet Vered Segre, Andrew R Hamel, Jiali Wang, John Rouhana, Tavé van Zyl, Wenjun Yan, Alexi mcadams, Aboozar Monavarfeshani, Qingnan Liang, Rui Chen, Joshua R. Sanes, Janey L Wiggs; Integrating gene regulation and single cell expression with genetic associations identifies genes and cell types contributing to primary open angle glaucoma risk and intraocular pressure. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1132.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : There is no cure for primary open-angle glaucoma (POAG), characterized by progressive optic nerve damage and vision loss, due to limited understanding of the molecular and cellular causes. Here we aimed to identify genes and cell types that may affect POAG risk by integrating known POAG and intraocular pressure (IOP) genetic loci with genetic regulation of gene expression (eQTLs) and splicing (sQTLs), and single cell expression in ocular tissues.

Methods : We developed a method called ECLIPSER, that tests whether expression of genes mapped to genome-wide association study (GWAS) loci of a complex trait, based on e/sQTLs, is enriched in specific cell types. For each trait, tissue, and cell type, a GWAS locus is scored based on the fraction of cell type-specific genes (fold-change>1.3, FDR<0.1). Cell type enrichment of a GWAS loci set is assessed against a null distribution of loci of unrelated traits taken from Open Target Genetics, using a Bayesian Fisher’s exact test. We mapped genes to 127 POAG loci and 133 IOP loci found in large GWAS meta-analyses, by applying colocalization methods, eCAVIAR and enloc, to the GWAS loci and overlapping e/sQTLs from 49 GTEx tissues and retina eQTLs (EyeGEx). GeneEnrich was used for gene set enrichment in biological processes.

Results : ≥1 e/sQTL colocalized with 61% (202 loci) of POAG and IOP GWAS loci (Posterior Prob>0.01), with an average of 3-4 genes per locus. POAG genes were enriched in elastic fiber formation and extracellular matrix organization (P<6E-05, FDR<0.01), and IOP genes in vasculature development (P=5E-05, FDR=0.13). Applying ECLIPSER to the mapped genes and single-nucleus RNA-seq of the anterior segment (AS), optic nerve head (ONH) and retina from healthy eyes, identified significant enrichment (P=0.01-4E-04, FDR=0.008-0.16) for POAG in astrocyte and Müller glia in ONH and retina, and ciliary and iris fibroblasts in the aqueous outflow pathway in AS. The IOP genes were enriched in smooth muscle, astrocyte, pericyte, and vascular endothelium in ONH, astrocyte in retina, and trabecular meshwork and ciliary fibroblasts in AS (P=0.001-0.009, FDR=0.02-0.15).

Conclusions : This work suggests hundreds of regulatory mechanisms and genes that may contribute to POAG risk in specific cell types in the front and back of the eye, which could help guide novel therapies.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×